درباره ما
درباره دکتر
دکتر حسین یحیی زاده
دکتر سید حسین یحیی زاده ، متخصص رادیوتراپی و کلینیکال انکولوژی دارای فلوشیپ رادیوتراپی پیشرفته از کشور آمریکا است . همچنین ایشان موسس مرکز جامع سلامت نگین آزادی در تهران می باشند .
رادیوتراپی
شیمی درمانی
هورمون درمانی
تارگت تراپی و ایمونوتراپی
درباره دکتر
مقالات منتشر شده
Burden of tracheal, bronchus, and lung cancer in North Africa and Middle East countries, 1990 to 2019: Results from the GBD study 2019
Frontiers in Oncology. Volume 12 – 2022 https://doi.org/10.3389/fonc.2022.1098218
Anatomical Distribution of Colon Cancer: A Retrospective 10-year Study to Evaluate Rightward Shift in Two Referral Hospitals in Iran
International Journal of Cancer Management. 2022 December; 15(12):e128897. DOI: https://doi.org/10.5812/ijcm-128897
Evaluation of lymph node adequacy in patients with colorectal cancer: Results from a referral center in Iran
Forum of Clinical Oncology. 13(1) • 2022 •1–6. DOI: 10.2478/fco-2022-0005
Gastrointestinal Neuroendocrine Tumors: A Single Center Experience
Forum of Clinical Oncology • 13(1) • 2022 •1–6. DOI: 10.2478/fco-2022-0004
The Burden of Prostate Cancer in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study
Frontiers in Oncology.13 September 2022. DOI 10.3389/fonc.2022.961086
Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study
Lancet Global Health 2022; 10: e1395–411. DOI:https://doi.org/10.1016/S2214-109X(22)00332-1
Assessing performance on the Healthcare Access and Quality Index by age group for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
Lancet Global Health. Published Online October 6, 2022. https://doi.org/10.1016/ S2214-109X(22)00429-6
The global burden of cancer attributable to risk factors, 2010–19,a systematic analysis for the Global Burden of Disease Study 2019
Lancet 2022; 400: 563–91. DOI:https://doi.org/10.1016/S0140-6736(22)01438-6
Age-sex differences in the global burden of lower respiratory infections and risk factors: results from the Global Burden of Disease Study 2019
Lancet Infection Disease. Published Online August 11, 2022
Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
Lancet. 2022 Apr 23;399(10335):1625-1645. Epub 2022 Apr 6. doi: 10.1016/S0140-6736(21)02751-3
Survival Study in Pediatric Patients with Medulloblastoma in a General Hospital in Tehran, Iran
Forum of Clinical Oncology. Published Online: 04 Jul 2022. DOI: https://doi.org/10.2478/fco-2021-0004
Primary Squamous Cell Carcinoma of Prostate With Direct Extension to Bladder
Acta Medica Iranica, Vol. 60, No. 5 (2022). https://doi.org/10.18502/acta.v60i5.9559
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet Gastroenterol Hepatol 2022. Published Online June 20, 2022 https://doi.org/10.1016/ S2468-1253(22)00124-8
Global, Regional and National Burden of Colorectal Cancer, 1990-2019: A systematic examination for Global Burden of Disease 2019
Lancet Gastroenterology & Hepatology 2022 Published Online April 7, 2022 https://doi.org/10.1016/ S2468-1253(22)00044-9
Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019
Lancet 2022; 399: 1625–45 Published Online April 6, 2022 https://doi.org/10.1016/ S0140-6736(21)02751-3
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
Lancet Diabetes Endocrinol. Published Online February 7, 2022 https://doi.org/10.1016/ S2213-8587(21)00349-1
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Lancet Public Health 2022 Published Online January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
JAMA Oncol. Published online December 30, 2021. doi:10.1001/jamaoncol.2021.6987
The global burden of adolescent and young adult cancer in 2019: An analysis of the Global Burden of Disease Study 2019
Lancet Oncol 2022; 23: 27–52. Published Online December 3, 2021 https://doi.org/10.1016/ S1470-2045(21)00581-7
Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet. 2021 Oct 30; 398(10311): 1593–1618. doi: 10.1016/S0140-6736(21)01546-4
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019
Lancet HIV 2021; 8: e633–51. DOI:https://doi.org/10.1016/S2352-3018(21)00152-1
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019
Lancet Infect Dis 2021 Published Online September 23, 2021 https://doi.org/10.1016/ S1473-3099(21)00449-7
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
Nature Medicine VOL 27 October 2021 1761–1782. doi: 10.1038/s41591-021-01498-0
A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review
Reproductive Biology and Endocrinology (2021) 19:147. https://doi.org/10.1186/s12958-021-00831-z
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet Neurol 2021; 20: 795–820. https://doi.org/10.1016/ S1474-4422(21)00252-0
Global, regional, and national progress toward Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
Lancet 2021. Published online August 17, 2021 https://doi.org/10.1016/S0140-6736(21)01207-1
Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019
Lancet 2021; 397: 996–1009. DOI:https://doi.org/10.1016/S0140-6736(21)00516-X
Mapping routine measles vaccination in low- and middle-income countries
Nature, Vol 589, 21 January 2021. DOI: https://doi.org/10.1038/s41586-020-03043-4
Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
Lancet Glob Health 2020; 8: e1038–60. DOI:https://doi.org/10.1016/S2214-109X(20)30230-8
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet 2020; 396: 1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
Lancet 2020; 396: 1160–203. DOI:https://doi.org/10.1016/S0140-6736(20)30977-6
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet 2020; 396: 1223–49. DOI:https://doi.org/10.1016/S0140-6736(20)30752-2
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet 2020; 396: 1250–84. https://doi.org/10.1016/ S0140-6736(20)30750-9
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
Nature Medicine | VOL 26 | May 750 2020 | 750–759. https://doi.org/10.1038/s41591-020-0807-6
Five insights from the Global Burden of Disease Study 2019
Lancet 2020; 396: 1135–59. DOI:https://doi.org/10.1016/S0140-6736(20)31404-5
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
Lancet Glob Health 2020; 8: e1162–85. DOI:https://doi.org/10.1016/S2214-109X(20)30278-3
Synchronous Early Breast Cancer and Locally Advanced Primary Bladder Adenocarcinoma
Int J Cur Res Rev | Vol 12 • Issue 10 • May 2020. DOI: http://dx.doi.org/10.31782/IJCRR.2020.12104
Evaluation Of The Prognostic Level Of PSA In Patients With Prostate Cancer Undergoing Orchiectomy And Drug Therapy
International Journal of Current Medical And Pharmaceutical Research, Vol. 6, Issue, 04(A), pp. 5072-5079, April, 2020. DOI: http://dx.doi.org/10.24327/23956429.ijcmpr202004868
Breast Cancer Screening Among Medical Staff in Tehran, Iran: Improvement of Early Detection
Acta Medica Iranica, Vol. 58, No. 1 (2020). DOI: https://doi.org/10.18502/acta.v58i1.3704
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet Gastroenterol Hepatol. VOLUME 5, ISSUE 3, P245-266, MARCH 01, 2020. https://doi.org/10.1016/S2468-1253(19)30349-8
Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017
The Lancet. VOLUME 395, ISSUE 10239, P1779-1801, JUNE 06, 2020 https://doi.org/10.1016/S0140-6736(20)30114-8
Mapping exclusive breastfeeding in Africa between 2000 and 2017
Nature Medicine volume 25, pages1205–1212(2019). https://doi.org/10.1038/s41591-019-0525-0
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
JAMA Oncology. 2019;5(12):1749-1768. doi:10.1001/jamaoncol.2019.2996
Patient Flow Analysis in General Hospitals: How Clinical Disciplines Affect Outpatient Wait Times
Hosp Pract Res. 2019 Dec;4(4):128-133
Developing a Quality Registry Network on Colorectal Cancer Care (QRN-CRC) in Iran; report of the pilot phase
NAACCR - IACR 2019 | June 9 – 13, 2019
Disease Free Survival for Non-Metastatic Colorectal Cancer Cases in Three Referral Hospitals in Iran. Interim Report of the CRC Quality Registry Network (QRN-CRC)
NAACCR - IACR 2019 | June 9 – 13, 2019
Lymphovascular and Perineural Invasions Are Independently Associated with Advanced Colorectal Carcinoma
Int J Cancer Manag. 2019 November; 12(11):e95540. doi: 10.5812/ijcm.95540
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurol. 2019 May;18(5):439-458. doi: 10.1016/S1474-4422(19)30034-1. Epub 2019 Mar 11
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
NATURE VOLUME 574, pages353–358(2019). https://doi.org/10.1038/s41586-019-1545-0
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet Gastroenterol Hepatol 2019.VOLUME 4, ISSUE 12, P934-947, DECEMBER 01, 2019. https://doi.org/10.1016/S2468-1253(19)30347-4
The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet Gastroenterol Hepatol 2019. VOLUME 4, ISSUE 12, P913-933, DECEMBER 01, 2019https://doi.org/10.1016/S2468-1253(19)30345-0
The Accuracy of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast Cancer Patients
A Single Institution Experience, INTERNATIONAL JOURNAL OF CANCER MANAGEMENT. DEC 2018. Volume: 11. Issue: 12. Article Number: e83946. DOI: 10.5812/ijcm.83946
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017
a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018. Volume: 392. Issue: 10159. Pages: 1736-1788. DOI: 10.1016/S01406736(18)32203-7
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017
a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018 . Volume: 392. Issue: 10159. Pages: 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017
a systematic analysis for the Global Burden of Disease Study 2017 , LANCET . NOV 10 2018. Volume: 392 .Issue: 10159. Pages: 1859-1922 . DOI: 10.1016/S0140-6736(18)32335-3
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017
a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018. Volume: 392. Issue: 10159. Pages: 1923-1994. DOI: 10.1016/S0140-6736(18)32225-6
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories
a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018; Volume: 392. Issue: 10159. Pages: 20912138. DOI: 10.1016/S0140-6736(18)32281-5
Number of Lymph Nodes Assessed in Iranian Gastric Cancer patients
Basic & Clinical Cancer Research, 2018; 10(1): 12-21
Association Between Surgical Margin Status and Local Recurrence in Iranian Patients Suffering from Colorectal Cancer
Int J Cancer Manag. 2018 November; 11(11):e83029
Male Adenoid Cystic Carcinoma of Breast
International Journal of Cancer Management (IJCM). 2017 September; 10(9):e7827
Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients
International Journal of Cancer Management (IJCM). 2017 April; 10(4):e6260
Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors
Asian Pacific Journal of Cancer Prevention, Vol 17, 2016, PP:249- 254
Malignant Retroperitoneal Hemangiopericytoma: Report of a 73 Years Old Woman and Review of Literature
Thrita Vol. 2, Issue 2, Nov 2013 PP:80-3
The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine
Iranian Journal of Cancer Prevention, Vol. 6, No. 3, Summer 2013 PP: 133-140
Pediatric Cancers that need radiotherapy in Iran: 30 years of one hospital
Data analysis Iranian Journal of Cancer Prevention, Vol. 1, No. 1, January 2008. PP: 17- 22
Comparison of Artificial Neural Network and Cox Regression Models in Survival Prediction of Breast Cancer Patients
Scientific Journal of Ilam University of Medical Sciences, Vol. 22, No. 2, Spring 2013 PP:120-128
Complete Chemotherapeutic Regression of a Non- Metastatic of Primary Pure Small Cell Carcinoma of the Prostate Current Urology,
An international journal for new findings in urologyVol. 6, No. 1, 2012 May 2012 PP: 43-45
Truth-telling to Cancer Patients from Relatives Point of View: A Multi-centre Study in Iran
Austral - Asian Journal of Cancer ISSN-0972-2556, Vol.6, No.4 - October 2007
Quality of Sleep in Cancer Patients: Evidences from Persian Translation of Pittsburgh Sleep Quality Index
Austral - Asian Journal of Cancer ISSN-0972-2556, Vol. 6, No.3, July 2007 PP: 165 – 168
Heterogeneity in Disease-Free Survival in Breast Cancer Patients
Journal of Clinical Oncology, 2007 ASCO Annual Meeting, Vol. 25, June 20th 2007: 11106
Treatment and Prognosis of Epithelial Ovarian Cancer in Iran
Journal of Clinical Oncology, 2007 ASCO Annual Meeting, Vol. 25, June 20th 2007: 5586
Post-op RT Improved Local control & Survival in Tongue Cancer Patients
Medical Social Security journal, 6th Year, April / May 2007 PP: 177 - 180
Prognostic Factors in 100 Patients of Gastric AC in Fayazbakhsh Hospital (SSO)
Medical Social Security journal, 6th Year, No. 32-33 Dec.2006/march 2007. PP: 76 - 79
Erb-B2 and P53 Expression as Predictive Factors in High-Grade Osteosarcoma
Cancer Bulletin of the Cancer Institute of Iran, Vol. 1 spring 2006: pp: 45 - 50
The Results of Surgery and Postoperative Radiotherapy on Local Control and Survival in Advanced Stage Carcinoma Base of Tongue
Journal of Thoracic Oncology, Vol.1 No.7 Oct. 2006 PP.: 916 - 917
ECG changes in left breast cancer patients following Chemotherapy and Radiotherapy, (Phase1 Trial),
Pajouhandeh (Researcher Journal of Shahid Beheshti University of Medical Science), Vol. 6 No.6 (26) winter, 2001-02 PP.: 503-506
+20
سال
تجربه در زمینه تشخیص و درمان انواع سرطان
+500
بیمار
معالجه شده توسط جناب دکتر
خدمات
انواع سرطان ها
سرطان هایی که توسط دکتر حسین یحیی زاده درمان می شوند .
سرطان های سر و گردن
سرطان‌های سر و گردن که در دهان، لب، بینی، سینوس‌ها، حنجره و گلو بروز می‌کنند.
بیشتر
تلفن
02162756000
09912453963
ایمیل
info@dr-yahyazadeh.com
آدرس مطب
خيابان آزادي- چهارراه اسكندري- برج نگين-مركزجامع سلامت نگين آزادي-بخش راديوتراپي انكولوژي
روزهای کاری
- شنبه الی چهارشنبه 16:00 - 21:00
نظرات بیماران
بازخورد بیماران
جناب دکتر یحیی زاده از بهترین های انکولوژی هستن و با تدابیر ایشون پدر بنده درمان شد
محمد مومنی
بیمار
آقای دکتر از بهترین ها هستند
نگار فضلی
بیمار
ایشون بسیار با تجربه هستند و از بهترین متخصصان رادیوتراپی تهران هستند
میلاد حسینی
بیمار
حال مادرم بسیار وخیم بود که خوشبختانه جناب دکتر درمانشون کردن . انشالله همیشه سلامت باشن
محدثه حدادی
بیمار